Who has invested in CRISPR Therapeutics?

Versant Ventures are named among the investors backing CRISPR Therapeutics.

CRISPR Therapeutics Funding: $25M Raised, Series A (2014)

CRISPR Therapeutics funding overview

CRISPR Therapeutics has raised $25M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2014. The round record for CRISPR Therapeutics runs through 2014; nothing later has been disclosed. Investors on record include Versant Ventures.

CRISPR Therapeutics at a glance

Total raised: $25M
Latest round: Series A
Latest round date: April 2014
Notable investors: Versant Ventures

Frequently asked about CRISPR Therapeutics funding

How much has CRISPR Therapeutics raised?: CRISPR Therapeutics has raised $25M in total disclosed funding across the rounds on record.
Who has invested in CRISPR Therapeutics?: Versant Ventures are named among the investors backing CRISPR Therapeutics.
What was the latest CRISPR Therapeutics funding round?: The most recent disclosed round is a Series A, announced in April 2014.
Where is CRISPR Therapeutics based?: No headquarters location is disclosed for CRISPR Therapeutics.
When did CRISPR Therapeutics last raise?: The last disclosed CRISPR Therapeutics round closed in April 2014 at Series A.

Totals shown for CRISPR Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.

CRISPR Therapeutics Funding: $25M Raised, Series A (2014)

CRISPR Therapeutics funding overview

CRISPR Therapeutics at a glance

Frequently asked about CRISPR Therapeutics funding

Companies related to CRISPR Therapeutics (18)

Browse related funding lists (4)